“Oncocytoid Renal Cell Carcinomas After Neuroblastoma” Represent TSC-mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas
暂无分享,去创建一个
J. McKenney | P. Argani | Ming-Tseh Lin | R. Mehra | L. Medeiros | E. Baraban | A. Bendel | B. Pawel | A. Matoso | J. Gagan | S. Falzarano | D. Palsgrove | T. Lotan | A. Pallavajjalla | Jawhar Rawwas | Sachin Patel | MD Pedram Argani | MD L. Jeffrey Medeiros | MD †‡ Andres Matoso | MD Ezra Baraban | MD Tamara Lotan | MD ∥ Bruce R. Pawel | MD¶ Jesse K. McKenney | MD Rohit Mehra | MD Sara M. Falzarano | MS †‡ Aparna Pallavajjalla | MD Ming-Tseh Lin | MD †† Sachin Patel | MD Jawhar Rawwas | MD Anne E. Bendel | MD Jeffrey Gagan | §§ Doreen N. Palsgrove PhD
[1] A. Davidoff,et al. Nephron-sparing surgery for Wilms tumor , 2023, Frontiers in Pediatrics.
[2] D. Kwiatkowski,et al. Diagnosis of Mosaic Tuberous Sclerosis Complex Using Next-Generation Sequencing of Subtle or Unusual Cutaneous Findings , 2022, JID innovations : skin science from molecules to population health.
[3] Mingde Zhao,et al. TSC/MTOR-associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum , 2022, The American journal of surgical pathology.
[4] Lisa M Haley,et al. Xanthomatous Giant Cell Renal Cell Carcinoma , 2022, The American journal of surgical pathology.
[5] P. Argani,et al. GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms , 2022, The Journal of pathology.
[6] J. Cheville,et al. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.
[7] C. Antonescu,et al. Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC) , 2020, The American journal of surgical pathology.
[8] A. Sangoi,et al. Low‐grade oncocytic tumour of kidney (CD117‐negative, cytokeratin 7‐positive): a distinct entity? , 2019, Histopathology.
[9] S. Dhanasekaran,et al. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. , 2018, European urology.
[10] I. Bottillo,et al. Identification of a novel TSC2 c.3610G > A, p.G1204R mutation contribute to aberrant splicing in a patient with classical tuberous sclerosis complex: a case report , 2018, BMC Medical Genetics.
[11] P. Argani,et al. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum , 2018, The American journal of surgical pathology.
[12] Lauren L. Ritterhouse,et al. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? , 2018, The American journal of surgical pathology.
[13] P. Argani,et al. Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients , 2018, Histopathology.
[14] J. McKenney,et al. Eosinophilic solid and cystic renal cell carcinomas have metastatic potential , 2018, Histopathology.
[15] J. Ginsberg,et al. Acquired Multiple Cysts of the Kidney in Neuroblastoma Survivors. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] S. Dhanasekaran,et al. Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms , 2016, The American journal of surgical pathology.
[17] R. Varadhan,et al. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation , 2016, Leukemia.
[18] C. Porta,et al. Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma , 2016, Clinical Cancer Research.
[19] A. Sangoi,et al. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women , 2016, The American journal of surgical pathology.
[20] Ling Lin,et al. Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing , 2015, PLoS genetics.
[21] D. Kwiatkowski,et al. Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2 , 2015, European Journal of Human Genetics.
[22] P. Argani,et al. t(6;11) Renal Cell Carcinoma (RCC): Expanded Immunohistochemical Profile Emphasizing Novel RCC Markers and Report of 10 New Genetically Confirmed Cases , 2014, The American journal of surgical pathology.
[23] E. Thiele,et al. Central TSC2 missense mutations are associated with a reduced risk of infantile spasms , 2013, Epilepsy Research.
[24] R. Ekong,et al. Functional Assessment of TSC2 Variants Identified in Individuals with Tuberous Sclerosis Complex , 2013, Human mutation.
[25] E. Levy-Lahad,et al. PGD for germline mosaicism. , 2012, Reproductive biomedicine online.
[26] M. Ladanyi,et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions , 2011, Modern Pathology.
[27] B. Taillon,et al. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex , 2010, Human Genetics.
[28] S. Tickoo,et al. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. , 2007, Urology.
[29] M. Ladanyi,et al. Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Mei-Ping Ding,et al. [Analysis of gene mutation in patients with tuberous sclerosis complex with polymerase chain reaction-single strand conformation polymorphism]. , 2003, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[31] E. Nanba,et al. Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex , 2002, Brain and Development.
[32] A. Hodges,et al. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. , 2001, Human molecular genetics.
[33] D. Kwiatkowski,et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. , 2001, American journal of respiratory and critical care medicine.
[34] G. Kovacs,et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. , 1999, The American journal of surgical pathology.
[35] V. Reuter,et al. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm , 2019, The American journal of surgical pathology.
[36] Marilyn M. Li,et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.
[37] D. Kwiatkowski,et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.